OBI Pharma
Taiwan - TaipeiPharmaceutical
Focus: OBI Pharma is a Taiwan-based biologics company focused on oncology with a pipeline of immunotherapy and targeted cancer programs. The company operates as a clinical-stage biotech with multiple programs across solid tumors and hematologic malignancies.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About OBI Pharma
AI assessmentNot HiringNo open roles listed right now. Follow OBI Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
OBI-833/OBI-821
Metastatic Gastric CancerClinical Trials (1)
NCT02310464Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
Phase 1Help build intelligence for OBI Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.